Clinuvel Pharmaceuticals (CUV.AU) Q3 2021 Earnings

26AugConfirmed
Feb 20
Aug 20
Q1 2021
Q3 2021
0
0.12
0.24
0.36

Details

Expected EPS
N/A
Actual EPS
0.36
Surprise EPS
0.36
Surprise Percent
+∞%

Description

Clinuvel Pharmaceuticals (CUV.AU) has reported earnings of 0.36 per share for Q3 2021.

0 Comments

Share your thoughts